Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16)

Genes Chromosomes and Cancer

Volumn 41, Issue 3, 2004, Pages 257-265

  Zhang, Yanming ^a   Zeleznik Le, Nancy ^b   Emmanuel, Neelmini ^a   Jayathilaka, Nimanthi ^a   Chen, Jianjun ^a   Strissel, Pamela ^a   Strick, Reiner ^a   Li, Loretta ^a   Neilly, Mary Beth ^a   Taki, Tomohiko ^c   Hayashi, Yasuhide ^c   Kaneko, Yasuhiko ^d   Schlegelberger, Brigitte ^e   Rowley, Janet D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d SAITAMA CANCER CENTER   (Japan)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE INHIBITOR;

ARTICLE; CANCER PATIENT; CBP GENE; CHILD; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENE CLUSTER; GENOMICS; HUMAN; HUMAN CELL; INTRON; LEUKEMIA; LEUKEMOGENESIS; MALE; MLL GENE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

AGED; BASE SEQUENCE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 16; COMPUTATIONAL BIOLOGY; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENOME; HUMANS; INTRONS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 4644279371     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20077     Document Type: Article

References (46)

1. Aoki K, Suzuki K, Sugano T, Tasaka T, Nakahara K, Kuge O, Omori A, Kasai M. 1995. A novel gene translin encodes a recombination hotspot binding protein associated with chromosomal translocations. Nat Genet 10:167-174.
2. Apian PD, Chervinsky DS, Stanulla M, Burhans WC. 1996. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87:2649-2658.
3. Atlas M, Head D, Behm F, Schmidt E, Zeleznik-Le NH, Roe BA, Burian D, Domer PH. 1998. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia 12: 1895-1902.
4. Borrow J, Stanton VPJ, Andresen JM, Becher R, Behm FG, Chaganti RSK, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14:33-41.
5. Chen SJ, Chen Z, Font MP, d'Auriol L, Larsen CJ, Berger R. 1989. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. Nucleic Acid Res 17:7631-7642.
6. Cheng JT, Yang CY, Hernandez J, Embrey J, Baer R. 1990. The chromosome translocation (11;14)(p13;q11) associated with T cell acute leukemia: asymmetric diversification of the translocational junctions. J Exp Med 171:489-501.
7. Domer PH, Head DR, Renganathan N, Raimondi SC, Yang E, Atlas M. 1995. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topo II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia 9:1305-1312.
8. Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ. 1995. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85:3250-3256.
9. Gillert E, Leis T, Repp R, Reichel M, Hosch A, Breitenlohner I, Angermuller S, Borkhardt A, Harbott J, Lampert F, Griesinger F, Greil J, Fey GH, Marschalek R. 1999. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18:4663-4671.
10. Gill-Super H, Strissel P, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-le NJ, Diaz MO, Rowley. 1997. Identification of complex genomic breakpoint junction in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer 10:185-195.
11. Hagan CR, Sheffield RF, Rudin CM. 2003. Human Alu element retrotransposition induced by genotoxic stress. Nat Genet 35: 219-20.
12. 3. Cancer Res 60:1139-1145.
13. Huret JL, Senon S. 2003. AML1. Atlas Genet Cytogenet Oncol Haematol. Available from: http://www.infobiogen.fr/services/chromcancer/Genes/AML1.html
14. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto K, Ohki M, Hayashi Y. 1997. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23; q12). Blood 90:4699-4704.
15. Jurka J, Klonowski P, Dagman V, Pelton P. 1996. CENSOR - a program for identification and elimination of repetitive elements from DNA sequences. Computers and Chemistry 20:119-122.
16. Khanna KK, Jackson SP. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247-254.
17. Kolomietz E, Meyn MS, Pandita A, Squire J. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35:97-112.
18. Langer T, Metzler M, Reinhardt D, Viehmann S, Borkhardt A, Reichel M, Stanulla M, Schrappe M, Creutzig U, Ritter J. Leis T, Jacobs U, Harbott J, Beck JD, Rascher W, Repp R. 2003. Analysis of t(9;ll) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer 36:393-401.
19. Lavau C, Du C, Thirman M, Zeleznik-Le N. 2000. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J 19:4655-4664.
20. Mirkovitch J, Mirault M, Laemmli UK. 1984. Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39:223-232.
21. Mitelman F, Johansson B, Mertens F. 2003. Mitelman Database of Chromosome Aberrations in Cancer. Available from: http://cgap.nci.nih.gov/Chromosomes/ Mitelman
22. Nilson I, Lochner K, Siegler G, Greil J, Beck JD, Fey GH, Marschalek R. 1996. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol 93:966-972.
23. Panagopoulos I, Fioretos T, Isaksson M, Samuelsson U, Billström R, Strömbeck B, Mitelman F, Johansson B. 2001. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 10:395-404.
24. Panagopoulos I, Isaksson M, Lindvall C, Hagemeijer A, Mitelman F, Johansson B. 2003. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13). Genes Chromosomes Cancer 36:90-98.
25. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen G-JB, Goodman RH, Peters DJM, Breuning MH. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348-355.
26. Reichel M, Gillert E, Nilson I, Siegler G, Greil J, Fey GH, Marschalek R. 1998. Fine structure of translocation breakpoints in leukemia blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene 17:3035-3044.
27. Reichel M, Gillert E, Angermueller S, Hensel JP, Heidel F, Lode M, Leis T, Biondi A, Hass OA, Strehl S, Panzer-Gruemayer ER, Griesinger F, Beck JD, Greil J, Fey GH, Uckin F, Marschalek R. 2001. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20:2900-2907.
28. Reiter A, Saussele S, Grimwade D, Wiemels JL, Segal M, Lafage-Pochitaloff M, Walz C, Weisser A, Hochhaus A, Willer A, Reichert A, Buechner T, Lengfelder E, Hehlmann R, Cross N. 2003. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia. Genes Chromosomes Cancer 36:175-188.
29. Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N. 1997. All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90:535-541.
30. Satake N, Ishida Y, Otoh Y, Hinohara S, Kobayashi H, Sakashita A, Maseki N, Kaneko Y. 1997. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11; 16)(q23;p13) chromosome translocation. Genes Chromosomes Cancer 20:60-63.
31. Schichman SA, Caligiuri MA, Strout MP, Carter SL, Gu Y, Canaani E, Bloomfield CD, Croce CM. 1994. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 54:4277-4280.
32. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ. 1997. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11:16)(q23;p13.3). Proc Natl Acad Sci USA 94:8732-8737.
33. Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD. 1997. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 17:4070-4079.
34. Strissel PL, Gill-Super HJ, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le NJ, Rowley JD. 1996. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topo II consensus binding site. Blood 87:1912-1919.
35. Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ. 1998. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92:3793-3803.
36. Strissel PL, Strick R, Tomek RJ, Roe BA, Rowley JD, Zeleznik-Le N. 2000. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 9: 1671-1679.
37. Strout MP, Marcucci G, Bloomfield CD, Caligiuri MA. 1998. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci USA 95:2390-2395.
38. Sugita K, Taki T, Hayashi Y, Shimaoka H, Kumazaki H, Inoue H, Konno Y, Taniwaki M, Kurosawa H, Eguchi M. 2000. MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosomes Cancer 27:264-269.
39. Taki T, Sako M, Tsuchida M, Hayashi Y. 1997. The t(11;16)(q23; p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89:3945-3950.
40. Thandla SP, Ploski JE, Raza-Egilmez SZ, Chhalliyil PP, Block AW, de Jong PJ, Aplan PD. 1999. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93:293-299.
41. Vizmanos JL, Larrayoz MJ, Lahortiga I, Floristan F, Alvarez C, Odero M, Novo FJ, Calasanz MJ. 2003. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia. Genes Chromosomes Cancer 36:402-405.
42. Wiemels JL, Alexander FE, Cazzaniga G, Biondi A, Mayer SP, Greaves M. 2000. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 29:219-228.
43. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG 1992. BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med 175:1575-1588.
44. Xiao Z, Greaves MF, Buffler P, Smith MT, Segal MR, Dicks BM, Wiencke JK, Wiemels JL. 2001. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Leukemia 15:1906-1913.
45. Zhang Y, Poetsch M, Weber-Matthiesen K, Rohde K, Winkemann M, Haferlach T, Gassmann W, Ludwig W-D, Grote W, Loffler H, Schlegelberger B. 1996. Secondary acute leukaemias with 11q23 rearrangement: Clinical, cytogenetic, FISH and FICTION studies. Br J Haematol 92:673-680.
46. Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau MM, Larson L and Rowley JD. 2002. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I HS sites in t(8;21) leukemia. Proc Natl Acad Sci USA 99:3070-3075.